Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio W Canonica

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 11, 2014
RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergyStefania La Grutta, Massimo Landi, Fulvio Braido, et al.
Allergy|May 20, 2020
Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitisEustachio Nettis, Vincenzo Patella, Carla Lombardo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 30, 2008
Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled studyMaurizio Marogna, Dante Tomassetti, Antonella Bernasconi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 9, 2025
Artificial Intelligence-Generated Answers to Patients' Questions on Asthma: The Artificial Intelligence Responses on Asthma StudyMattia Nigro, Andrea Aliverti, Alessandra Angelucci, et al.
ERJ Open Research|November 12, 2025
Mepolizumab in patients with severe asthma and blood eosinophil counts between 150 and 300 cells per µL: benefits at two yearsGiorgio W Canonica, Diego Bagnasco, Jason K Lee, et al.
The New England Journal of Medicine|September 1, 2016
Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide AloneStephen P Peters, Eugene R Bleecker, Giorgio W Canonica, et al.
Acta Dermato-Venereologica|September 16, 2011
Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validityEmek Kocatürk, Karsten Weller, Peter Martus, et al.
Allergy|April 27, 2022
Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergensEkaterina Potapova, Véronique Bordas-Le Floch, Thomas Schlederer, et al.
Current Opinion in Allergy and Clinical Immunology|October 3, 2017
Critical appraisal of the unmet needs in the treatment of chronic spontaneous urticaria with omalizumab: an Italian perspectiveRiccardo Asero, Giorgio W Canonica, Antonio Cristaudo, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|November 23, 2011
The IgE repertoire in children and adolescents resolved at component level: a cross-sectional studyGiovanni Melioli, Laura Marcomini, Alessia Agazzi, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 11, 2014
RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergyStefania La Grutta, Massimo Landi, Fulvio Braido, et al.
Allergy|May 20, 2020
Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitisEustachio Nettis, Vincenzo Patella, Carla Lombardo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 30, 2008
Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled studyMaurizio Marogna, Dante Tomassetti, Antonella Bernasconi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 9, 2025
Artificial Intelligence-Generated Answers to Patients' Questions on Asthma: The Artificial Intelligence Responses on Asthma StudyMattia Nigro, Andrea Aliverti, Alessandra Angelucci, et al.
ERJ Open Research|November 12, 2025
Mepolizumab in patients with severe asthma and blood eosinophil counts between 150 and 300 cells per µL: benefits at two yearsGiorgio W Canonica, Diego Bagnasco, Jason K Lee, et al.
The New England Journal of Medicine|September 1, 2016
Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide AloneStephen P Peters, Eugene R Bleecker, Giorgio W Canonica, et al.
Acta Dermato-Venereologica|September 16, 2011
Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validityEmek Kocatürk, Karsten Weller, Peter Martus, et al.
Allergy|April 27, 2022
Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergensEkaterina Potapova, Véronique Bordas-Le Floch, Thomas Schlederer, et al.
Current Opinion in Allergy and Clinical Immunology|October 3, 2017
Critical appraisal of the unmet needs in the treatment of chronic spontaneous urticaria with omalizumab: an Italian perspectiveRiccardo Asero, Giorgio W Canonica, Antonio Cristaudo, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|November 23, 2011
The IgE repertoire in children and adolescents resolved at component level: a cross-sectional studyGiovanni Melioli, Laura Marcomini, Alessia Agazzi, et al.
Pageof 8